Pro-inflammatory pathways in post-infarction intramyocardial vasculature

Pro-inflammatory pathways in post-infarction intramyocardial vasculature" is a descriptive term for the array of inflammatory molecular and cellular pathways active within the small blood vessels of the heart after myocardial infarction. Key mediators and events include the release of damage-associated molecular patterns (DAMPs), activation of the complement cascade, and stimulation of pattern recognition receptors such as Toll-like receptor 4 (TLR4), leading to activation of inflammatory signaling (e.g., NF-κB), cytokine and chemokine release, generation of reactive oxygen species, and interleukin-1 production[1][3][5][7][8]. These cascades drive leukocyte infiltration, endothelial activation, microvascular dysfunction, and tissue injury, as well as play essential roles in subsequent tissue repair and scar formation[3][5][7][8]. This term does not represent a singular molecular target or druggable entity, but rather a collection of interconnected pathways involving multiple cell types, enzymes, receptors, and soluble mediators. Key points: - There is no single canonical molecule, receptor, or abbreviation; the term aggregates diverse processes[1][3][5][7][8]. - While some components (e.g., TLR4[1], complement system[1], cytokine receptors[3]) are therapeutic targets, the overall pathway is not itself a discretely druggable target. - The term is overly broad for purposes requiring specific molecular identification and should be replaced with a defined target, such as "Toll-like receptor 4" or "complement component 3". - Additional research and drug development are underway to modulate select molecular players within these pathways for treating adverse remodeling and chronic heart failure after myocardial infarction[1][4][8].

Other names

Post-infarction inflammatory pathwaysPro-inflammatory signaling in myocardial vasculaturePost-MI vascular inflammatory cascades